Process-Based Psychological Processes in Alcohol Use Disorder: A Case-Control Study Using PBAT, PHQ-9, and GAD-7

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGeorge Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures

About this trial

This observational study investigates differences in psychological processes and emotional symptoms between individuals with Alcohol Use Disorder (AUD) and a non-clinical control group. PBAT, PHQ-9, and GAD-7 will be used. MANCOVA will test group differences controlling for demographics.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age ≥18, the ability to provide informed consent, no psychiatric diagnosis (for the control group).

Disqualifiers

severe cognitive impairment, psychosis, inability to complete questionnaires.

Trial population

Primary care clinic, community sample.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

200 Participants
are grouped into 2 trial groups
Group A: Clinical
Group B: Control

Trial outcomes

Primary outcomes

1

Process-Based Assessment Tool

The scale involves the depiction of psychological and behavioral processes involved in adaptation and maladaptation, according to the Extended Evolutionary Meta-Model. The scale includes 18 items, each involving a stand-alone, individual score, indicating the degree to which the responder engages in the specific process. The scale comprises both positive and negative behavioral strategies.

Time frame
After enrollment (single time point).

Secondary outcomes

1

Patient Health Questionnaire-9 (PHQ-9)

The scale involves the assessment of depressive symptoms, with a score range between 0 and 27. Scores between 5 and 9 mean mild depression, 10 to 14 moderate depression, 15 to 19 moderate to severe depression and above 20 severe depression (Kroenke et al., 2001).

Time frame
After enrollment (single time point).
2

Generalized Anxiety Disorder-7 (GAD-7)

The scale involves the assessment of anxiety symptoms, with a score range from 0 to 21. Scores between 5 and 9 indicate mild anxiety, scores between 10 and 14 moderate anxiety, while those above 15 show severe anxiety.

Time frame
After enrollment (single time point).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: